ALVO
ALVO
Positions held
Your positionsALVO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headlines — positive tone
• [OK · fundamentals] ALVO Stock Jumps On Double Upgrade — Why Barclays Sees A 59% Upside
• [OK · fundamentals] Alvotech Shares Rise After Double Upgrade From Barclays
• [OK · fundamentals] Why This Biotech Stock Just Got a Rare Double Upgrade
News
2026-10-08 · LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply
2026-10-08 · Alvotech (ALVO) Could Be 14% Undervalued On Manufacturing Capacity Updates
2026-10-06 · Alvotech, Lotte Biologics Sign US Manufacturing Agreement for Biosimilar Medicines
2026-10-06 · Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
2026-10-06 · Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
2026-10-05 · Alvotech Soars 13% on FDA Nod That “Effectively Doubles” US Humira Biosimilar Capacity
2026-10-05 · Alvotech stock surges after FDA manufacturing approval
2026-10-05 · Sector Update: Healthcare Stocks Steady Pre-Bell Monday
2026-10-05 · Alvotech Gets US FDA Approval For Additional Manufacturing Capacity For Simlandi Biosimilar; Shares Up Pre-Bell
2026-10-05 · FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
2026-10-05 · FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
2026-09-16 · Why This Biotech Stock Just Got a Rare Double Upgrade
Price (daily)
Full chart · RSI · MACD · patterns